Publikation:

Modeling of Pharmacokinetics and Pharmacodynamics with Application to Cancer and Arthritis

Lade...
Vorschaubild

Dateien

Diss_Koch.pdf
Diss_Koch.pdfGröße: 1.57 MBDownloads: 1597

Datum

2012

Autor:innen

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

DOI (zitierfähiger Link)
ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Open Access Green
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Dissertation
Publikationsstatus
Published

Erschienen in

Zusammenfassung

Mathematical modeling of pharmacokinetics / pharmacodynamics (PKPD) is an important and growing field in drug development. In this work we develop preclinical PKPD models based on fundamental biological and pharmacological principles.

Equipped with a PKPD model, different dosing schedules could be simulated and therefore, a valuable contribution to first in human dose selection could be achieved. We consider different mathematical model figures and discuss the properties and biological basis. Such tools serve as modules for a final PKPD model. We apply ordinary and delay differential equations and especially focus on modeling of delays and lifespans in populations. We show a fundamental relationship between transit compartments and lifespan models. Moreover, we investigate the weighted least squares estimator and derive statistical characteristics of model parameter.

We present a PKPD model to describe tumor growth and anticancer effects for mono- and combination therapy. Further, we construct a PKPD model for arthritis development and antibody effects.

Summarizing, we develop (semi)-mechanistic mathematical PKPD models based on pharmacological assumptions and apply our models to measured data from preclinical phase.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
310 Statistik

Schlagwörter

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690KOCH, Gilbert, 2012. Modeling of Pharmacokinetics and Pharmacodynamics with Application to Cancer and Arthritis [Dissertation]. Konstanz: University of Konstanz
BibTex
@phdthesis{Koch2012Model-19472,
  year={2012},
  title={Modeling of Pharmacokinetics and Pharmacodynamics with Application to Cancer and Arthritis},
  author={Koch, Gilbert},
  address={Konstanz},
  school={Universität Konstanz}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/19472">
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39"/>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/19472/2/Diss_Koch.pdf"/>
    <dcterms:abstract xml:lang="eng">Mathematical modeling of pharmacokinetics / pharmacodynamics (PKPD) is an important and growing field in drug development. In this work we develop preclinical PKPD models based on fundamental biological and pharmacological principles.&lt;br /&gt;&lt;br /&gt;Equipped with a PKPD model, different dosing schedules could be simulated and therefore, a valuable contribution to first in human dose selection could be achieved. We consider different mathematical model figures and discuss the properties and biological basis. Such tools serve as modules for a final PKPD model. We apply ordinary and delay differential equations and especially focus on modeling of delays and lifespans in populations. We show a fundamental relationship between transit compartments and lifespan models. Moreover, we investigate the weighted least squares estimator and derive statistical characteristics of model parameter.&lt;br /&gt;&lt;br /&gt;We present a PKPD model to describe tumor growth and anticancer effects for mono- and combination therapy. Further, we construct a PKPD model for arthritis development and antibody effects.&lt;br /&gt;&lt;br /&gt;Summarizing, we develop (semi)-mechanistic mathematical PKPD models based on pharmacological assumptions and apply our models to measured data from preclinical phase.</dcterms:abstract>
    <dc:language>eng</dc:language>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-06-14T08:50:19Z</dc:date>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:issued>2012</dcterms:issued>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dcterms:title>Modeling of Pharmacokinetics and Pharmacodynamics with Application to Cancer and Arthritis</dcterms:title>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/19472/2/Diss_Koch.pdf"/>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/19472"/>
    <dc:creator>Koch, Gilbert</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Koch, Gilbert</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-06-14T08:50:19Z</dcterms:available>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

May 25, 2012
Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen